diethylcarbamazine has been researched along with Optic Nerve Diseases in 1 studies
Diethylcarbamazine: An anthelmintic used primarily as the citrate in the treatment of filariasis, particularly infestations with Wucheria bancrofti or Loa loa.
Optic Nerve Diseases: Conditions which produce injury or dysfunction of the second cranial or optic nerve, which is generally considered a component of the central nervous system. Damage to optic nerve fibers may occur at or near their origin in the retina, at the optic disk, or in the nerve, optic chiasm, optic tract, or lateral geniculate nuclei. Clinical manifestations may include decreased visual acuity and contrast sensitivity, impaired color vision, and an afferent pupillary defect.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cousens, SN | 1 |
| Yahaya, H | 1 |
| Murdoch, I | 1 |
| Samaila, E | 1 |
| Evans, J | 1 |
| Babalola, OE | 1 |
| Zakari, M | 1 |
| Abiose, A | 1 |
| Jones, BR | 1 |
1 other study available for diethylcarbamazine and Optic Nerve Diseases
| Article | Year |
|---|---|
Risk factors for optic nerve disease in communities mesoendemic for savannah onchocerciasis, Kaduna State, Nigeria.
Topics: Adolescent; Adult; Aged; Case-Control Studies; Child; Diethylcarbamazine; Female; Humans; Infant; Ma | 1997 |